LifeMine Therapeutics
2 known investors
LifeMine is a biopharmaceutical company that uses data science and advanced methods to accelerate drug discovery and develop precision medicines across therapeutic areas.
AI & Machine LearningBiotechDeep Tech
Investors · 2
In the news
- LifeMine Announces First Participant Dosed in First-in-human Phase 1 Clinical Trial of LIFE-001, Designed De Novo to Become a Field Dominating Immunosuppressive for Immune-mediated Disorders and Transplantationbusinesswire.com · 2025
- GSK-Backed LifeMine Nets $175M and More Financing News - BioSpacebiospace.com · 2022
- LifeMine locks down $70M 'dream scenario' fungi partnership with GSK—and a fundraising, too | Fierce Biotechfiercebiotech.com · 2022
- LifeMine Therapeutics Announces $175 Million Series C Financingbusinesswire.com · 2022
- LifeMine Therapeutics raises USD175m in Series C round led by Fidelity Management & Research Company - Private Equity Wireprivateequitywire.co.uk · 2022
- LifeMine raises $175m to find drugs from fungi - The Boston Globebostonglobe.com · 2022